Despite significant improvements to CLL treatment, including the advent of BCR inhibitors (Burger et al, 2015) and BH3‐mimetics (Fischer et al, 2019), CLL remains incurable. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.